Please assess the completion status of the following clinical trial:

Trial Title: Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* COVID-19 cases~* Oxygen saturation \> 93%~* Age \>18 years~Exclusion Criteria:~* Patients \<18 years,~* patients with Oxygen saturation \< 93%, patients with~* Diabetes mellitus or~* heart failure,~* patients on chemotherapy or immunosuppressive therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- clarithromycin (Type: EXPERIMENTAL): clarithromycin group
- Azithromycin (Type: ACTIVE_COMPARATOR): azithromycin group
- control (Type: PLACEBO_COMPARATOR): control group

Based on this trial design, predict the completion outcome and termination type (if applicable).